Decoding the secrets of life with single-molecular translatomics: A revolutionary strategy in biology Authors: Zhihui Lu, Genxiang Bai, Lin Zhang, Shoudong Zhang, Ming Luo Published: 2026 Introduction The central dogma of molecular biology outlines the flow of sequence information from nucleic acids to proteins; however, transcript abundance serves as an imperfect surrogate for proteome composition. Indeed, mRNA levels account for only ∼40% of the variance in protein abundance, with translation rate, rather than transcription, dictating cellular protein output.1 In contrast, translatomics, which entails the genome-wide quantification of actively translating mRNAs, provides a functional readout of gene expression that surpasses the resolution of transcriptomics. While established techniques, including polysome profiling, ribosome profiling (Ribo-seq), and translating ribosome affinity purification (TRAP), have significantly propelled the study of translational control, their coupling with conventional sequencing has relied primarily on short-read cDNA libraries. Consequently, the native, full-length mRNA molecules engaged by ribosomes remain largely unexplored. Recent breakthroughs in DRS2 now enable the direct examination of native RNA molecules. If ONT DRS is coupled with mRNAs isolated from translation-associated fractions, it will profile the traits of translating mRNAs. In this review, we assess existing translatome methodologies and envisage the promising prospect of single-molecule translatomics. Methods for translatome profiling Polysome profiling was originally conceptualized based on RNA-linked multi-ribosome complexes engaged in protein synthesis. Subsequent sucrose-gradient-based polysome analysis facilitated the separation of mRNAs according to their degree of ribosome association. When integrated with RNA sequencing (RNA-seq), polysome-seq serves as a genome-wide proxy for transcript-level ribosome occupancy; however, its capacity to resolve transcript isoforms, untranslated region (UTR) architecture, and poly(A)-tail characteristics is constrained by the limitations of short-read libraries. For instance, Ribo-seq yields only ribosome footprints, precluding identification of the specific transcript isoform being translated, as well as the resolution of phased modifications and poly(A) tails on individual molecules. TRAP-seq and RiboTag enable the retrieval of epitope-tagged ribosomes from specific cell types in vivo, while ribosome–nascent chain complex-bound mRNA sequencing (RNC-seq) isolates intact ribosome-nascent-chain complexes to recover full-length translating mRNAs. Transcript isoforms in polysomes sequencing (TrIP-seq) pioneered isoform-aware polysome profiling, demonstrating that alternative 5′ and 3′ UTR isoforms can drive up to 100-fold differences in translational output,3 yet it remained reliant on short Illumina reads. Collectively, these methodologies are hampered by three fundamental structural limitations: reverse transcription and PCR introduce sequence and length biases; chemical modifications and poly(A) tails are lost during library preparation; and short reads fail to associate distal exons, UTRs, modifications, and poly(A) tails with a single translating molecule. DRS can annotate nearly all information of translating mRNAs ONT DRS enables the full-length sequencing of native RNA molecules.2 This capability facilitates the comprehensive profiling of transcript isoforms, encompassing insights into pre-mRNA processing, poly(A)-tail length, and base modifications. When integrated with polysome profiling, DRS allows for the systematic investigation of how specific RNA characteristics influence translational efficiency. While current research on the impact of base modifications on translation is predominantly centered on m6A, ONT DRS also offers the capacity to detect m5C, pseudouridine, and inosine (Figure 1). This broad detection scope introduces a novel dimension for exploring the interplay between diverse RNA modifications and translational regulation.Figure 1Polysome fractionation coupled with ONT direct RNA sequencing for single-molecule translatomics(A) polysome-mRNA extraction and Direct RNA sequencing.(B) Multi-layer information extraction from a single native RNA read.(C) Comparison of ribosome-associated sequencing methods. Polysome fractionation coupled with ONT direct RNA sequencing for single-molecule translatomics (A) polysome-mRNA extraction and Direct RNA sequencing. (B) Multi-layer information extraction from a single native RNA read. (C) Comparison of ribosome-associated sequencing methods. Technical integration of polysome fractionation with direct RNA sequencing A robust polysome DRS workflow requires the tight coupling of biochemical ribosome fractionation with preservation of native RNA features. Translation is first stabilized by rapid harvesting, flash freezing, and, where appropriate, cycloheximide treatment to limit ribosome runoff before lysis. Cells or tissues are then lysed under Mg2+-rich, RNase-protective conditions to maintain ribosome-mRNA association, and clarified cytoplasmic extracts are separated on linear sucrose gradients. During fractionation, A254 profiles typically resolve ribosomal subunits, monosomes, light polysomes, and heavy polysomes.4 Heavy polysome fractions are enriched for highly ribosome-loaded mRNAs and are often used as a proxy for active translation, although they cannot by themselves distinguish increased initiation from slowed elongation or ribosome pausing. RNA recovered from selected fractions must then be purified under conditions compatible with native RNA-seq and assessed for integrity, size distribution, and rRNA contamination. Because standard ONT DRS preferentially sequences polyadenylated RNA, poly(A)+ enrichment or rRNA depletion is usually required to obtain efficient mRNA coverage. A major practical bottleneck is the input amount: fractionated polysome RNA is often scarce, whereas current ONT RNA004 chemistry recommends approximately 300 ng poly(A)-tailed RNA, with lower inputs typically reducing sequencing output.5 Library construction then proceeds through adapter and motor-protein ligation to the RNA 3′ end, followed by ONT sequencing. Robust experimental design should include matched total or cytoplasmic input RNA for estimating isoform-level ribosome association, EDTA-treated lysate to test Mg2+-dependent polysome integrity, puromycin or related controls where compatible with the system, and sufficient biological replication to support differential isoforms, poly(A)-tails, and modification-sensitive analyses. Despite its conceptual promise, polysome DRS is constrained by several interconnected bottlenecks. The first limitation lies in input quantity. Individual polysome fractions frequently yield RNA amounts below the recommended threshold (300 ng poly(A)-tailed RNA). While low-input native RNA strategies, such as solid-phase catalysis-based library preparation, can mitigate sample loss during DRS library construction, they do not fully address the challenges posed by rare samples, clinical biopsies, or highly fractionated gradients. Conversely, cDNA-PCR long-read workflows circumvent the input constraint but at the expense of DRS’s native RNA advantages, notably the direct detection of RNA modifications. Second, although RNA004 chemistry has enhanced direct RNA read accuracy and output, robust single-nucleotide modification calling is challenging and generally demands a minimum per-site coverage of ∼20 reads, and a recent RNA004 benchmark showed that Dorado reaches high recall for m6A only at sites with ≥10× coverage and ≥10% modification ratio; Ψ detection demands even deeper coverage due to the absence of a strong motif. Effective detection further requires unmodified or depletion controls and orthogonal validation. Third, computational tools remain fragmented and lack standardization. Benchmarking of nanopore m6A callers has revealed substantial precision-recall trade-offs, limited inter-tool concordance, and a strong dependence of performance on sequencing depth and ground-truth selection. Many tools developed for earlier RNA002 data or mammalian datasets cannot be directly extrapolated to RNA004 signals or plant transcriptomes without retraining and validation since the altered ionic current signals between the two chemicals for RNA-seq. Furthermore, plant polysome-DRS pipelines necessitate species-specific benchmarking and validation via orthogonal methods, including m⁶A individual-nucleotide-resolution cross-linking and immunoprecipitation (miCLIP), m⁶A-selective allyl chemical labeling and sequencing (m6A-SAC-seq), methylated RNA immunoprecipitation sequencing (MeRIP-seq), or targeted biochemical assays. Fourth, throughput and cost impose practical constraints on experimental design. Although RNA004 offers higher output than previous DRS chemistries, native RNA-seq remains less cost-effective than short-read RNA-seq for large-scale factorial studies, particularly when multiple polysome fractions, stress conditions, genotypes, and biological replicates are sequenced independently. Given the error profile of ONT sequencing, is short-read RNA-seq required for correction? The short answer is no. First, RNA004 chemistry greatly improves the accuracy of base calling; second, the well-assembled genome can be used to correct base-calling errors in long reads after mapping them to a reference genome. Finally, cross-study reproducibility remains a persistent challenge, as pore chemistry, adapter set, translocation dynamics, base-caller version, and modification-calling model all influence the ionic-current signatures essential for native RNA analysis. Until standardized reference datasets, spike-in standards, and benchmarking frameworks are established, polysome DRS results should be interpreted as relative, workflow-dependent measurements rather than platform-independent absolute quantifications. Future outlook: single-molecule translatomics as a lens on major biological questions Single-molecule polysome DRS provides a revolutionary lens for exploring biological questions where phenotype defies explanation by transcript abundance alone. By principle, it forges direct links between isoform identity, UTR architecture, poly(A)-tail length, and modification-sensitive signals on a per-molecule basis within translation-associated fractions. A compelling example is maize heterosis, where this technology moves beyond the limitations of transcriptomics to not only pinpoint the genes that truly underpin heterosis but also to uncover why these genes are decisive, even when their dominance is absent in comparative translatomics (data not shown). In the realm of cancer, it promises to identify the key genes of tumorigenesis and decode their functional roles, capturing not just the dramatic shifts in final protein products but also the mRNA-level features that drive their synthesis. Extending its reach to fundamental biological processes, from aging and circadian rhythms to neurodegeneration, single-molecule translatomics stands as a powerful tool, primed not only to decode these phenomena but to catalyze a paradigm shift in our understanding of biology. Funding and acknowledgments The authors are thankful for funding from Yunnan Provincial Major Basic Research Projects (202401BC070003) to S.Z.; the National Natural Science Foundation of China (NSFC) Regional Science Foundation Projects (32460487) to S.Z.; Yunnan Provincial Major Science and Technology Special Projects (202502AE090006) to S.Z.; the Guangdong Natural Science Funds for Distinguished Young Scholars (2022B1515020026) to M.L.; and the Youth Innovation Promotion Association, Chinese Academy of Sciences (Y2021094) to M.L. Declaration of interests M.L. is an academic editor of The Innovation.